Across TCGA pan-cancer cohorts, MTND1P12 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated MTND1P12 data layer.
The strongest signal is observed in breast invasive carcinoma (BRCA), where higher MTND1P12 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTND1P12 expression acts as an unfavorable survival marker.
BRCA, LUSC, and SKCM are the cancer types where MTND1P12 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.